Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Opus Genetics, Inc. has filed 1,054 SEC EDGAR filings since 29 Apr 2003

SEC filing history

Showing 726-750 of 860 matching filings.

Per page
25
Current page
30
DEF 14A File 001-34079

REXAHN PHARMACEUTICALS, INC DEF 14A 6-9-2014

Filing date
18 Apr 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Apr 2014
Reporting date
14 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-34079

REXAHN PHARMACEUTICALS, INC PRE 14A 6-9-2014

Filing date
28 Mar 2014
Reporting date
09 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34079

REXAHN PHARMACEUTICALS, INC 10-K 12-31-2013

Filing date
21 Mar 2014
Reporting date
31 Dec 2013
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Mar 2014
Reporting date
26 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 2-26-2014

Filing date
03 Mar 2014
Reporting date
26 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 1-21-2014

Filing date
21 Jan 2014
Reporting date
21 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-175073

REXAHN PHARMACEUTICALS INC 424B5 1-15-2014

Filing date
17 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-175073

REXAHN PHARMACEUTICALS, INC 424B5 1-16-2014

Filing date
17 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 1-14-2014

Filing date
15 Jan 2014
Reporting date
14 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2014
Reporting date
12 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2014
Reporting date
12 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2014
Reporting date
12 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2014
Reporting date
12 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 1-14-2014

Filing date
14 Jan 2014
Reporting date
14 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79996

SABBY 13G-A RNN 01.07.14

Filing date
07 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2013

Filing date
13 Nov 2013
Reporting date
30 Sep 2013
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC. 8-K 10-10-2013

Filing date
16 Oct 2013
Reporting date
10 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-175073

REXAHN PHARMACEUTICALS 424B5 10-10-2013

Filing date
15 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79996

AHN CHANG HO SC 13D A NO 5 10-7-2013 (REXAHN PHARMACEUTICALS, INC)

Filing date
09 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Sep 2013
Reporting date
09 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34079

REXAHN PHARMACEUTICALS, INC 8-K 8-25-2013

Filing date
29 Aug 2013
Reporting date
25 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34079

REXAHN PHARMACEUTICALS INC 10-Q 6-30-2013

Filing date
12 Aug 2013
Reporting date
30 Jun 2013
Next action
Verify source filing
8-K File 001-34079

FORM 8-K

Filing date
24 Jul 2013
Reporting date
23 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .